Induction of A. fumigatus-specific CD4-positive T cells in patients recovering from invasive aspergillosis

Haematologica

Volumn 99, Issue 7, 2014, Pages 1255-1263

  Jolink, Hetty ^a   Hagedoorn, Renate S ^a   Lagendijk, Ellen L ^b   Drijfhout, Jan W ^a   van Dissel, Jaap T ^a   Frederik Falkenburg, J H ^a   Heemskerk, Mirjam H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B LIPID COMPLEX; BUSULFAN; CASPOFUNGIN; CATALASE; CD40 LIGAND; EPITOPE; FLUDARABINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; THYMOCYTE ANTIBODY; VORICONAZOLE; FUNGUS ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; ASPERGILLUS FUMIGATUS; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE ASPERGILLOSIS; LYMPHOCYTE CLONE; MALE; MIDDLE AGED; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REMISSION; TH1 CELL; ADVERSE EFFECTS; ALLOTRANSPLANTATION; ASPERGILLOSIS; COMPUTED TOMOGRAPHY SCANNER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; IMMUNOPHENOTYPING; INVASIVE PULMONARY ASPERGILLOSIS; METABOLISM;

ADULT; AGED; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; PHENOTYPE; T-CELL ANTIGEN RECEPTOR SPECIFICITY; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TRANSPLANTATION, HOMOLOGOUS;

EID: 84903642399     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.098830     Document Type: Article

References (19)

1. Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, et al. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study-Sorveglianza epidemiologica infezioni fungine nelle emopatie maligne. Clin Inf Dis. 2007;45(9):1161-70.
2. Bozza S, Gaziano R, Lipford GB, Montagnoli C, Bacci A, di Francesco P, et al. Vaccination of mice against invasive aspergillosis with recombinant Aspergillus proteins and CpG oligodeoxynucleotides as adjuvants. Microbes Infect. 2002;4(13): 1281-90.
3. Bozza S, Perruccio K, Montagnoli C, Gaziano R, Bellocchio S, Burchielli E, et al. A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood. 2003;102(10):3807-14.
4. Cenci E, Mencacci A, Bacci A, Bistoni F, Kurup VP, Romani L. T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol. 2000;165(1):381-8.
5. Hebart H, Bollinger C, Fisch P, Sarfati J, Meisner C, Baur M, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood. 2002;100(13):4521-8.
6. Perruccio K, Tosti A, Burchielli E, Topini F, Ruggeri L, Carotti A, et al. Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. Blood. 2005;106(13):4397-406.
7. Bozza S, Clavaud C, Giovannini G, Fontaine T, Beauvais A, Sarfati J, et al. Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol. 2009;183(4):2407-14.
8. Chaudhary N, Staab JF, Marr KA. Healthy human T-cell responses to Aspergillus fumigatus antigens. PLoS One. 2010;5(2): e9036.
9. Khanna N, Stuehler C, Conrad B, Lurati S, Krappmann S, Einsele H, et al. Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood. 2011;118(4):1121-31.
10. Ramadan G, Konings S, Kurup VP, Keever-Taylor CA. Generation of Aspergillus-and CMV-specific T-cell responses using autologous fast DC. Cytotherapy. 2004;6(3): 223-34.
11. Ramadan G, Davies B, Kurup VP, Keever-Taylor CA. Generation of Th1 T cell responses directed to a HLA class II restricted epitope from the Aspergillus f16 allergen. Clin Exp Immunol. 2005;139(2):257-67.
12. Stuehler C, Khanna N, Bozza S, Zelante T, Moretti S, Kruhm M, et al. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood. 2011;117 (22):5881-91.
13. Zhu F, Ramadan G, Davies B, Margolis DA, Keever-Taylor CA. Stimulation by means of dendritic cells followed by Epstein-Barr virus-transformed B cells as antigen-presenting cells is more efficient than dendritic cells alone in inducing Aspergillus f16-specific cytotoxic T cell responses. Clin Exp Immunol. 2008;151(2):284-96.
14. Jolink H, Meijssen IC, Hagedoorn RS, Arentshorst M, Drijfhout JW, Mulder A, et al. Characterization of the T-cell-mediated immune response against the Aspergillus fumigatus proteins Crf1 and Catalase 1 in healthy individuals. J Infect Dis. 2013;208 (5):847-56.
15. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-21.
16. Cenci E, Mencacci A, Del Sero G, Bacci A, Montagnoli C, d'Ostiani CF, et al. Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis. 1999;180(6):1957-68.
17. Chai LY, Vand V, Marijnissen RJ, Cheng SC, Khoo AL, Hectors M, et al. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology. 2010;130(1):46-54.
18. Boeckh M, Huang M, Ferrenberg J, Stevens-Ayers T, Stensland L, Nichols WG, et al. Optimization of quantitative detection of cytomegalovirus DNA in plasma by realtime PCR. J Clin Microbiol. 2004;42(3): 1142-8.
19. Tormo N, Solano C, Benet I, Nieto J, de la CR, Garcia-Noblejas A, et al. Kinetics of cytomegalovirus (CMV) pp65 and IE-1-specific IFNgamma CD8+ and CD4+ T cells during episodes of viral DNAemia in allogeneic stem cell transplant recipients: potential implications for the management of active CMV infection. J Med Virol. 2010; 82(7):1208-15.